from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3810/pirG

LFCtreatmentdescriptionclass of inhibitor

1.439

Amikacinug/mL Amikacintranslation

1.343

Cap5-10ug/mL Capreomycintranslation

1.400

Rox10-50 ug/mL Roxithromycintranslation

-0.850

SM2-5 ug/mL Streptomycintranslation

-0.397

Tet5-10 ug/mL Tetracyclinetranslation

-1.713

Rif0.2-5ug/mL Rifampicintranscription

-0.747

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.289

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.590

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.253

CPZ10-50 ug/mL Chlorpromazinerespiration

0.225

Clofazimine10-13 ug/mL Clofaziminerespiration

0.291

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.285

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.292

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.065

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.381

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.439

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.006

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.322

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.242

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.134

KCN5-20 ug/mL Potassium cyaniderespiration

0.455

NaN30.2-2 mM Sodium aziderespiration

0.618

Nigericin50 uM Nigericinrespiration

0.404

TRC10-150 ug/mL Triclosanrespiration

0.873

TRZ10-25 ug/mL Thioridazinerespiration

-0.405

Valinomycin0.5-10 uM Valinomycinrespiration

0.865

ZnSO42 mM ZnSO4respiration

-0.268

menadione6-10 ug/mL Menadionerespiration

-2.020

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.356

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-1.035

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.064

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-2.506

NRP_1Non-replicating persistence stage 1dosRassociated

1.204

Amp0.2mg/mL AmpicillincellWall

0.522

Cephalexin20-100 ug/mL CephalexincellWall

0.439

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.122

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.604

EMB10-20 ug/mL EthambutolcellWall

1.137

Eta12-40 ug/mL EthionamidecellWall

1.018

INH0.2-0.4 ug/mL IsoniazidcellWall

0.606

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.793

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.505

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.060

BZA0.12 mg/mL BenzamidearomaticAmides

-0.230

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.309

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.651

H2O24 mM hydrogen peroxideDNAdamaging

-0.515

Levo10 ug/mL LevofloxacinDNAdamaging

-0.622

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.440

Novobiocin10 ug/mL NovobiocinDNAdamaging

-1.881

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.571

UVUV-irradiationDNAdamaging

-0.688

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.951

Antimycin12.5-50 ug/mL Antimycin A?

0.023

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.448

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.100

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.346

PA8240.2-2 ug/mL PA-824?

0.139

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.250

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.396

Verapamil50 uM Verapamil?

0.029

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.336

methoxatin10-20 ug/mL Methoxatin?